UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cardiovascular Disease in Systemic Lupus Erythematosus: Recent Data on Epidemiology, Risk Factors and Prevention

Current vascular pharmacology, 2020-01, Vol.18 (6), p.549-565

2020

Volltextzugriff (PDF)

The role of plasma exchange in antineutrophil cytoplasmic antibody-associated vasculitis: a meta-analysis

Clinical rheumatology, 2021-04, Vol.40 (4), p.1447-1456

2021

Volltextzugriff (PDF)

Impaired serotonin synthesis in hippocampus of murine lupus represents an early neuropsychiatric event

Lupus, 2024-02, Vol.33 (2), p.166-171

2024

Volltextzugriff (PDF)

Relapses are common in severe hematologic systemic lupus erythematosus and may be prevented by early institution of immunosuppressive agents: Α real-life single-center study

Lupus, 2023-02, Vol.32 (2), p.225-230

2023

Volltextzugriff (PDF)

Janus kinase inhibitors in systemic lupus erythematosus: implications for tyrosine kinase 2 inhibition

Frontiers in medicine, 2023, Vol.10, p.1217147-1217147

2023

Volltextzugriff (PDF)

Restoration of aberrant gene expression of monocytes in systemic lupus erythematosus via a combined transcriptome-reversal and network-based drug repurposing strategy

BMC genomics, 2023-04, Vol.24 (1), p.207-207, Article 207

2023

Volltextzugriff (PDF)

P110 Impact of neuropsychiatric involvement on health-related quality of life in patients with systemic lupus erythematosus

Lupus science & medicine, 2024-03, Vol.11 (Suppl 1), p.A119-A119

2024

Volltextzugriff (PDF)

O28 Unveiling the impact of neuropsychiatric involvement in systemic lupus erythematosus on damage accrual

Lupus science & medicine, 2024-03, Vol.11 (Suppl 1), p.A28-A29

2024

Volltextzugriff (PDF)

From first symptoms to diagnosis of systemic lupus erythematosus: mapping the journey of patients in an observational study

Clinical and experimental rheumatology, 2023-01, Vol.41 (1), p.74

2023

Volltextzugriff (PDF)

Clinical response trajectories and drug persistence in systemic lupus erythematosus patients on belimumab treatment: A real-life, multicentre observational study

Frontiers in immunology, 2023-01, Vol.13, p.1074044

2023

Volltextzugriff (PDF)

A network-based approach reveals long non-coding RNAs associated with disease activity in lupus nephritis: key pathways for flare and potential biomarkers to be used as liquid biopsies

Frontiers in immunology, 2023-07, Vol.14, p.1203848-1203848

2023

Volltextzugriff (PDF)

Transition to severe phenotype in systemic lupus erythematosus initially presenting with non-severe disease: implications for the management of early disease

Lupus science & medicine, 2020-06, Vol.7 (1), p.e000394

2020

Volltextzugriff (PDF)

P61 Harnessing machine learning to predict neuropsychiatric events in systemic lupus erythematosus

Lupus science & medicine, 2024-03, Vol.11 (Suppl 1), p.A85-A86

2024

Volltextzugriff (PDF)

P62 Machine learning approaches for prediction of renal flares in systemic lupus erythematosus: knowledge-driven models outperformed data-driven models

Lupus science & medicine, 2024-03, Vol.11 (Suppl 1), p.A86-A86

2024

Volltextzugriff (PDF)

O11 Unsupervised machine-learning identifies distinct clusters based on B cell phenotyping and autoantibody profiles in patients with systemic lupus erythematosus

Lupus science & medicine, 2024-03, Vol.11 (Suppl 1), p.A14-A15

2024

Volltextzugriff (PDF)

P23 Presence of anti-Sm autoantibodies is associated with abatement of attainability of LLDAS and DORIS remission in systemic lupus erythematosus

Lupus science & medicine, 2024-03, Vol.11 (Suppl 1), p.A59-A59

2024

Volltextzugriff (PDF)

Demyelinating Syndromes in Systemic Lupus Erythematosus: Data From the "Attikon" Lupus Cohort

Frontiers in neurology, 2022-05, Vol.13, p.889613-889613

2022

Volltextzugriff (PDF)

P88 Baseline factors associated with subsequent development of incident nephritis in patients with systemic lupus erythematosus: a retrospective cohort study

Lupus science & medicine, 2024-03, Vol.11 (Suppl 1), p.A105-A106

2024

Volltextzugriff (PDF)

O15 B cell, T cell, cytotoxic/NK cell, and mitochondrial gene dysregulation patterns separate neuropsychiatric systemic lupus erythematosus patients into two distinct subgroups with differential anticipated response to targeted therapies

Lupus science & medicine, 2024-03, Vol.11 (Suppl 1), p.A17-A18

2024

Volltextzugriff (PDF)

O23 Interferon upregulation and B and plasma cell gene dysregulation patterns reveal three distinct lupus nephritis subgroups with differential anticipated response to targeted therapies

Lupus science & medicine, 2024-03, Vol.11 (Suppl 1), p.A24-A25

2024

Volltextzugriff (PDF)

O13 Innate immunity transcriptional profiles as potential predictive biomarkers for treatment response in systemic lupus erythematosus: Insights from a longitudinal study

Lupus science & medicine, 2024-03, Vol.11 (Suppl 1), p.A16-A16

2024

Volltextzugriff (PDF)

Update on the pathogenesis of central nervous system lupus

Current opinion in rheumatology, 2019-11, Vol.31 (6), p.669-677

2019

Volltextzugriff (PDF)

Treatment of neuropsychiatric systemic lupus erythematosus: clinical challenges and future perspectives

Expert review of clinical immunology, 2021-04, Vol.17 (4), p.317-330

2021

Volltextzugriff (PDF)

Microglia activation in the presence of intact blood–brain barrier and disruption of hippocampal neurogenesis via IL-6 and IL-18 mediate early diffuse neuropsychiatric lupus

Annals of the rheumatic diseases, 2023-05, Vol.82 (5), p.646-657

2023

Volltextzugriff (PDF)

Lupus or not? SLE Risk Probability Index (SLERPI): a simple, clinician-friendly machine learning-based model to assist the diagnosis of systemic lupus erythematosus

Annals of the rheumatic diseases, 2021-06, Vol.80 (6), p.758-766

2021

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(55)

Sprache

Englisch
(55)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Cardiovascular Disease in Systemic Lupus Erythematosus: Recent Data on Epidemiology, Risk Factors and Prevention

The role of plasma exchange in antineutrophil cytoplasmic antibody-associated vasculitis: a meta-analysis

Impaired serotonin synthesis in hippocampus of murine lupus represents an early neuropsychiatric event

Relapses are common in severe hematologic systemic lupus erythematosus and may be prevented by early institution of immunosuppressive agents: Α real-life single-center study

Janus kinase inhibitors in systemic lupus erythematosus: implications for tyrosine kinase 2 inhibition

Restoration of aberrant gene expression of monocytes in systemic lupus erythematosus via a combined transcriptome-reversal and network-based drug repurposing strategy

P110 Impact of neuropsychiatric involvement on health-related quality of life in patients with systemic lupus erythematosus

O28 Unveiling the impact of neuropsychiatric involvement in systemic lupus erythematosus on damage accrual

From first symptoms to diagnosis of systemic lupus erythematosus: mapping the journey of patients in an observational study

Clinical response trajectories and drug persistence in systemic lupus erythematosus patients on belimumab treatment: A real-life, multicentre observational study

A network-based approach reveals long non-coding RNAs associated with disease activity in lupus nephritis: key pathways for flare and potential biomarkers to be used as liquid biopsies

Transition to severe phenotype in systemic lupus erythematosus initially presenting with non-severe disease: implications for the management of early disease

P61 Harnessing machine learning to predict neuropsychiatric events in systemic lupus erythematosus

P62 Machine learning approaches for prediction of renal flares in systemic lupus erythematosus: knowledge-driven models outperformed data-driven models

O11 Unsupervised machine-learning identifies distinct clusters based on B cell phenotyping and autoantibody profiles in patients with systemic lupus erythematosus

P23 Presence of anti-Sm autoantibodies is associated with abatement of attainability of LLDAS and DORIS remission in systemic lupus erythematosus

Demyelinating Syndromes in Systemic Lupus Erythematosus: Data From the "Attikon" Lupus Cohort

P88 Baseline factors associated with subsequent development of incident nephritis in patients with systemic lupus erythematosus: a retrospective cohort study

O15 B cell, T cell, cytotoxic/NK cell, and mitochondrial gene dysregulation patterns separate neuropsychiatric systemic lupus erythematosus patients into two distinct subgroups with differential anticipated response to targeted therapies

O23 Interferon upregulation and B and plasma cell gene dysregulation patterns reveal three distinct lupus nephritis subgroups with differential anticipated response to targeted therapies

O13 Innate immunity transcriptional profiles as potential predictive biomarkers for treatment response in systemic lupus erythematosus: Insights from a longitudinal study

Update on the pathogenesis of central nervous system lupus

Treatment of neuropsychiatric systemic lupus erythematosus: clinical challenges and future perspectives

Microglia activation in the presence of intact blood–brain barrier and disruption of hippocampal neurogenesis via IL-6 and IL-18 mediate early diffuse neuropsychiatric lupus

Lupus or not? SLE Risk Probability Index (SLERPI): a simple, clinician-friendly machine learning-based model to assist the diagnosis of systemic lupus erythematosus

Suchergebnisse filtern